Instruments to assess upper-limb function in children and adolescents with neuromuscular diseases: a systematic

Gabriela Barroso De Queiroz Davoli1, Juliana Cardoso1, Giovanna Constantin Silva1

  • 1Department of Health Science, Ribeirão Preto Medical School, University of São Paulo, São Paulo, Brazil.

Insights

The Performance of Upper Limb (PUL) and Revised Upper Limb Module (RULM) are best for assessing upper-limb function in common pediatric neuromuscular diseases. More research is needed for other NMDs due to instrument limitations.

Area of Science:

  • Pediatric Neuromuscular Diseases
  • Clinical Assessment Tools
  • Upper Limb Function

Background:

  • Neuromuscular diseases (NMDs) significantly impact pediatric upper-limb function.
  • Standardized assessment tools are crucial for monitoring disease progression and treatment efficacy.
  • Existing instruments require rigorous evaluation for their suitability in pediatric NMD populations.

Purpose of the Study:

  • To systematically review and synthesize evidence on instruments for assessing upper-limb function in pediatric patients with NMD.
  • To evaluate the methodological quality and measurement properties of available assessment tools.
  • To identify gaps in current assessment strategies for pediatric NMDs.

Main Methods:

  • Systematic review adhering to PRISMA and COSMIN guidelines.
  • Searched PubMed/MEDLINE, LILACS, Embase, and Scopus databases.
  • Assessed methodological quality using the COSMIN Risk of Bias checklist and measurement property criteria.

Main Results:

  • Twelve instruments were identified across 34 articles, with Brooke Upper Extremity and PUL being most frequent.
  • The PUL and Duchenne muscular dystrophy (DMD) Upper Limb patient-reported outcome measures (PROMs) showed good properties for DMD.
  • The Revised Upper Limb Module (RULM) is suitable for spinal muscular atrophy; no instruments were found for Charcot-Marie-Tooth disease.

Conclusions:

  • Performance of Upper Limb (PUL), DMD Upper Limb PROM, and RULM are recommended for prevalent pediatric NMDs.
  • Significant gaps and methodological flaws necessitate the development of new, high-quality assessment instruments.
  • Further research is crucial to develop and validate tools for underrepresented pediatric NMDs.
Abstract